Sun, Dec 21, 2014, 1:14 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • terry_insm terry_insm Aug 15, 2013 8:43 PM Flag

    From" Phase3 ready " " near commercialization " to deja vu all over again.

    After iplex and now with Arikace, failures and disappointments in timelines and now US sales, those who have lost time and time again,now sound very familiar...... CF trials disappointed and I find it amazing our resident clowns are not facing the realization that CF revenues will be on the low side. There will be no US sales for years unless they trial.(US was the majority of revenue. estimates)
    Onto NTM says Will , and the sheep follow!... There will be no magic bullet in NTM either. If the results are "encouraging" the FDA will require a bit "additional work "(Will Lewis). I hope Insmed is successful but the hype of just 2 years ago and reality are here.
    YTD +125%

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It really has not sunk in here.Maybe in 2 years when they start selling(if).Yes it is amazing.

    • From" Phase3 ready " " near commercialization " to deja vu all over again.
      by terry_insm • 20 hours ago Flag
      After iplex and now with Arikace, failures and disappointments in timelines and now US sales, those who have lost time and time again,now sound very familiar...... CF trials disappointed and I find it amazing our resident clowns are not facing the realization that CF revenues will be on the low side. There will be no US sales for years unless they trial.(US was the majority of revenue. estimates)
      Onto NTM says Will , and the sheep follow!... There will be no magic bullet in NTM either. If the results are "encouraging" the FDA will require a bit "additional work "(Will Lewis). I hope Insmed is successful but the hype of just 2 years ago and reality are here.

      • 1 Reply to insm_truth_teller
      • From" Phase3 ready " " near commercialization " to deja vu all over again.
        by terry_insm • 20 hours ago Flag
        After iplex and now with Arikace, failures and disappointments in timelines and now US sales, those who have lost time and time again,now sound very familiar...... CF trials disappointed and I find it amazing our resident clowns are not facing the realization that CF revenues will be on the low side. There will be no US sales for years unless they trial.(US was the majority of revenue. estimates)
        Onto NTM says Will , and the sheep follow!... There will be no magic bullet in NTM either. If the results are "encouraging" the FDA will require a bit "additional work "(Will Lewis). I hope Insmed is successful but the hype of just 2 years ago and reality are here

    • $11.41 purrfect....Have fun weekend!

 
INSM
16.42+0.37(+2.31%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.